{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:55:06Z","timestamp":1753883706769,"version":"3.41.2"},"reference-count":25,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Parathyroid carcinoma (PC) and atypical parathyroid tumors (APT) are incompletely understood and pose challenges in definitive diagnosis. FLCN sequence variants have recently been linked to PC and APT. Inactivating mutations in the ubiquitously expressed FLCN tumor suppressor gene, encoding folliculin, cause Birt-Hogg-Dub\u00e9 syndrome (BHD), a rare tumor predisposition syndrome. Germline inactivating FLCN variants, accompanied by somatic allelic loss, were reported in 2 unrelated patents with PC, both with clinical features, but no diagnosis, of BHD. Somatic frameshift variants of likely pathogenicity were reported in 1 patient with PC and 1 with APT. On the other hand, neither PC nor APT has been reported in sizeable BHD series. To better understand the frequency of FLCN variants in PC and APT, we analyzed a series of 10 patients with sporadic PC and 14 with APT by direct Sanger DNA sequencing. We identified no inactivating FLCN mutations in any of the PC or APT samples examined. A germline missense variant (p.Gly325Val), predicted as benign\/tolerated, was seen in 1 PC and a synonymous variant in 1 APT. The absence of pathogenic mutations detected in our series of PC and APT further suggests that FLCN variants are rare in these tumors. Nevertheless, the potential roles of FLCN in the pathogenesis of PC and APT merits further consideration and study.<\/jats:p>","DOI":"10.1210\/jendso\/bvaf009","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T18:44:33Z","timestamp":1737139473000},"source":"Crossref","is-referenced-by-count":1,"title":["<i>FLCN<\/i> Variants in Parathyroid Carcinoma and Atypical Parathyroid Tumors"],"prefix":"10.1210","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8982-7214","authenticated-orcid":false,"given":"Callie Shea","family":"Burke","sequence":"first","affiliation":[{"name":"Center for Molecular Oncology, University of Connecticut School of Medicine , Farmington, CT 06030-3101 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Bellizzi","sequence":"additional","affiliation":[{"name":"Center for Molecular Oncology, University of Connecticut School of Medicine , Farmington, CT 06030-3101 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6437-1693","authenticated-orcid":false,"given":"Jessica","family":"Costa-Guda","sequence":"additional","affiliation":[{"name":"Center for Molecular Oncology, University of Connecticut School of Medicine , Farmington, CT 06030-3101 ,","place":["USA"]},{"name":"Center for Regenerative Medicine and Skeletal Development, University of Connecticut School of Dental Medicine , Farmington, CT 06030-3101 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8821-8527","authenticated-orcid":false,"given":"Andrew","family":"Arnold","sequence":"additional","affiliation":[{"name":"Center for Molecular Oncology, University of Connecticut School of Medicine , Farmington, CT 06030-3101 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"issue":"1","key":"2025020307455286200_bvaf009-B1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"7","key":"2025020307455286200_bvaf009-B2","doi-asserted-by":"crossref","first-page":"R441","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2025020307455286200_bvaf009-B3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.4203","article-title":"Complete genomic landscape of a recurring sporadic parathyroid carcinoma","volume":"230","author":"Kasaian","year":"2013","journal-title":"J Pathol"},{"issue":"2","key":"2025020307455286200_bvaf009-B4","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025020307455286200_bvaf009-B5","doi-asserted-by":"crossref","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"issue":"6","key":"2025020307455286200_bvaf009-B6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","article-title":"Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"2025020307455286200_bvaf009-B7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/js.2018-00043","article-title":"Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways","volume":"3","author":"Clarke","year":"2019","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025020307455286200_bvaf009-B8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.31948","article-title":"Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas","volume":"144","author":"Cui","year":"2019","journal-title":"Int J Cancer"},{"issue":"8","key":"2025020307455286200_bvaf009-B9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00432-019-02945-9","article-title":"Genetic profiling as a clinical tool in advanced parathyroid carcinoma","volume":"145","author":"Kutahyalioglu","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"2025020307455286200_bvaf009-B10","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/ijc.33166","article-title":"The genomic profile of parathyroid carcinoma based on whole-genome sequencing","volume":"147","author":"Hu","year":"2020","journal-title":"Int J Cancer"},{"issue":"7","key":"2025020307455286200_bvaf009-B11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/1878-0261.13398","article-title":"Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling","volume":"17","author":"Teleanu","year":"2023","journal-title":"Mol Oncol"},{"issue":"5","key":"2025020307455286200_bvaf009-B12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s12276-023-00968-4","article-title":"Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma","volume":"55","author":"Jo","year":"2023","journal-title":"Exp Mol Med"},{"key":"2025020307455286200_bvaf009-B13","doi-asserted-by":"crossref","first-page":"1027598","DOI":"10.3389\/fendo.2023.1027598","article-title":"Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"2025020307455286200_bvaf009-B14","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1210\/clinem\/dgab452","article-title":"Do patients with atypical parathyroid adenoma need close follow-up?","volume":"106","author":"Saponaro","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025020307455286200_bvaf009-B15","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2025020307455286200_bvaf009-B16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/clinem\/dgae441","article-title":"Whole-exome sequencing of atypical parathyroid tumors detects novel and common genes linked to parathyroid tumorigenesis","volume":"110","author":"Pardi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025020307455286200_bvaf009-B17","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1210\/clinem\/dgad136","article-title":"Germline- and somatic-inactivating FLCN variants in parathyroid cancer and atypical parathyroid tumors","volume":"108","author":"Jha","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025020307455286200_bvaf009-B18","first-page":"753694","article-title":"A rare soft tissue tumor masquerading as a parathyroid adenoma in a patient with birt-hogg-dube syndrome and multiple cervical endocrinopathies","volume":"2014","author":"Mikesell","year":"2014","journal-title":"Case Rep Pathol"},{"issue":"3","key":"2025020307455286200_bvaf009-B19","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.revmed.2010.01.016","article-title":"Birt-Hogg-Dube syndrome and multiple recurrent tumors]","volume":"32","author":"Vinit","year":"2011","journal-title":"Rev Med Interne"},{"issue":"5","key":"2025020307455286200_bvaf009-B20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-4362.1996.tb03642.x","article-title":"Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome","volume":"35","author":"Chung","year":"1996","journal-title":"Int J Dermatol"},{"issue":"8","key":"2025020307455286200_bvaf009-B21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/humu.21519","article-title":"Birt Hogg-Dube syndrome-associated FLCN mutations disrupt protein stability","volume":"32","author":"Nahorski","year":"2011","journal-title":"Hum Mutat"},{"issue":"6","key":"2025020307455286200_bvaf009-B22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","article-title":"Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome","volume":"76","author":"Schmidt","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"7993","key":"2025020307455286200_bvaf009-B23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"9","key":"2025020307455286200_bvaf009-B24","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.gim.2022.05.006","article-title":"Frequency of truncating FLCN variants and Birt-Hogg-Dube-associated phenotypes in a health care system population","volume":"24","author":"Savatt","year":"2022","journal-title":"Genet Med"},{"key":"2025020307455286200_bvaf009-B25","doi-asserted-by":"crossref","first-page":"667311","DOI":"10.3389\/fcell.2021.667311","article-title":"Folliculin: a regulator of transcription through AMPK and mTOR signaling pathways","volume":"9","author":"Ramirez Reyes","year":"2021","journal-title":"Front Cell Dev Biol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvaf009\/61489379\/bvaf009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/2\/bvaf009\/61489379\/bvaf009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/9\/2\/bvaf009\/61489379\/bvaf009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T07:46:05Z","timestamp":1738568765000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvaf009\/7959774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvaf009","relation":{},"ISSN":["2472-1972"],"issn-type":[{"type":"electronic","value":"2472-1972"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,6]]},"article-number":"bvaf009"}}